We are live on ! Find out more
INGN icon

Inogen

139 hedge funds and large institutions have $246M invested in Inogen in 2023 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 52 increasing their positions, 42 reducing their positions, and 34 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more call options, than puts

Call options by funds: $60K | Put options by funds: $20K

24% more repeat investments, than reductions

Existing positions increased: 52 | Existing positions reduced: 42

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

5.62% less ownership

Funds ownership: 97.58%91.96% (-5.6%)

7% less funds holding

Funds holding: 150139 (-11)

12% less capital invested

Capital invested by funds: $280M → $246M (-$34.5M)

32% less first-time investments, than exits

New positions opened: 23 | Existing positions closed: 34

Holders
139
Holders Change
-11
Holders Change %
-7.33%
% of All Funds
2.18%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
23
Increased
52
Reduced
42
Closed
34
Calls
$60K
Puts
$20K
Net Calls
+$40K
Net Calls Change
-$45K
Name Holding Trade Value Shares
Change
Change in
Stake
AQR Capital Management
26
AQR Capital Management
Connecticut
$2.53M +$716K +60,749 +38%
Jane Street
27
Jane Street
New York
$2.44M +$1.77M +150,131 +246%
Walleye Capital
28
Walleye Capital
New York
$2.38M +$1.49M +126,853 +160%
Northern Trust
29
Northern Trust
Illinois
$2.33M -$445K -37,768 -16%
Bank of America
30
Bank of America
North Carolina
$2.19M +$126K +10,704 +6%
CSS
31
Cubist Systematic Strategies
Connecticut
$2.18M +$1.4M +119,123 +171%
Arrowstreet Capital
32
Arrowstreet Capital
Massachusetts
$1.9M +$1.93M +164,147 New
Charles Schwab
33
Charles Schwab
California
$1.85M -$132K -11,203 -7%
Qube Research & Technologies (QRT)
34
Qube Research & Technologies (QRT)
United Kingdom
$1.72M +$1.51M +127,810 +602%
Goldman Sachs
35
Goldman Sachs
New York
$1.71M +$140K +11,913 +9%
HF
36
HRT Financial
New York
$1.71M +$1.74M +147,845 New
ECM
37
ExodusPoint Capital Management
New York
$1.69M +$65.4K +5,546 +4%
E
38
Ergoteles
New York
$1.58M +$1.33M +112,842 +464%
Susquehanna International Group
39
Susquehanna International Group
Pennsylvania
$1.54M +$984K +83,519 +169%
Acadian Asset Management
40
Acadian Asset Management
Massachusetts
$1.52M +$1.51M +127,967 +3,294%
Two Sigma Investments
41
Two Sigma Investments
New York
$1.51M +$934K +79,276 +153%
Assenagon Asset Management
42
Assenagon Asset Management
Luxembourg
$1.5M +$606K +51,434 +66%
Two Sigma Advisers
43
Two Sigma Advisers
New York
$1.33M +$433K +36,741 +47%
SCM
44
Sio Capital Management
New York
$1.29M -$118K -10,000 -8%
Norges Bank
45
Norges Bank
Norway
$1.27M
Bank of New York Mellon
46
Bank of New York Mellon
New York
$1.21M -$1.01M -85,806 -45%
EGM
47
Engineers Gate Manager
New York
$977K +$74.4K +6,311 +8%
MWM
48
Mission Wealth Management
California
$885K
Prudential Financial
49
Prudential Financial
New Jersey
$841K +$149K +12,645 +21%
KCM
50
Kennedy Capital Management
Missouri
$836K

INGN Hedge Fund Activity: Q2 2023 in Review

139 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Inogen (INGN) for Q2 2023, worth a combined $246M — down 12% from $280M a quarter earlier.

Sellers outnumbered buyers: 34 funds closed out of INGN and 23 opened new positions — a net loss of 11 holders — while 42 trimmed existing stakes and 52 added.

The largest buyer was Millennium Management, adding an estimated $5.25M. The largest seller was BlackRock, cutting an estimated $26.5M.

  • 139 institutional investors held Inogen (INGN) as of Q2 2023, down from 150 in Q1 2023.
  • Funds reported $246M of Inogen stock for Q2 2023, down 12% quarter-over-quarter.
  • 23 funds opened new Inogen positions in Q2 2023 and 34 closed out, a net change of -11 holders.
  • The largest Inogen buyer in Q2 2023 was Millennium Management, an estimated $5.25M added.
  • The largest Inogen seller in Q2 2023 was BlackRock, an estimated $26.5M sold.

Based on aggregated 13F filings for Q2 2023.